Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
GeoVax receives critical EMA Scientific Advice, enabling direct Phase 3 trial for Mpox vaccine. Significant milestone in vaccine development strategy advances global health preparedness #Vaccines #MedicalInnovation
2026-05-13T01:06:42.269Z